Table 14.3. Process and financial... | Emerald Publishing

Table 14.3.

Process and financial outcomes.

Patient Outcomes
Metric	Description	Baseline	ISPM	Delta^¹
Time spent at MDT		300 s	240 s	-20%^***
Patient’s view	What the patient wants or perceives about their treatment	1.86	2.15	+16%
Psychosocial	The patient’s social and psychological situation	2.08	2.63	+26%^**
Co-morbidity	Patient medical history	2.69	3.32	+23%^***
Pathology	Histopathological information	2.88	2.99	+4%^*
Imaging	Radiological information	4.95	4.96	0
History	Case history	3.96	3.99	+1%
Decision	Whether any relevant decisions were taken at the current MDT	4.68	4.71	+1%
Members	Did members contribute to the discussion	3.94	4.65	+18%^***
Chair	How did the leader affect the running of the MDT	3.10	4.44	+13%^***
Participation in discussion	Proportion of staff making a contribution to the discussion	36.4%	40.8%	+18%^*

Patient Outcomes
Metric	Description	Baseline	ISPM	Delta¹
Time spent at MDT		300 s	240 s	-20%^***
Patient’s view	What the patient wants or perceives about their treatment	1.86	2.15	+16%
Psychosocial	The patient’s social and psychological situation	2.08	2.63	+26%^**
Co-morbidity	Patient medical history	2.69	3.32	+23%^***
Pathology	Histopathological information	2.88	2.99	+4%^*
Imaging	Radiological information	4.95	4.96	0
History	Case history	3.96	3.99	+1%
Decision	Whether any relevant decisions were taken at the current MDT	4.68	4.71	+1%
Members	Did members contribute to the discussion	3.94	4.65	+18%^***
Chair	How did the leader affect the running of the MDT	3.10	4.44	+13%^***
Participation in discussion	Proportion of staff making a contribution to the discussion	36.4%	40.8%	+18%^*

Financial Outcomes
Metric	Baseline	ISPM	Delta
Accumulated cost saving per patient	101 kSEK	103 kSEK	+2%

1

Significance levels for the reported differences are shown as follows: ^*p < 0.05, ^**p < 0.01, ^***p < 0.001.